Bruce Martin

Bruce Martin is an accomplished finance professional with extensive experience in leadership roles across various organizations. Currently serving as Chief Financial Officer at NKD since March 2023, Bruce previously held the positions of Chief Operating Officer and Chief Financial Officer at The Writer from November 2019 to March 2023. Bruce's career includes roles such as Financial Controller at Selecta and Cell Therapy Catapult, and Head of Finance for the UK and France at Altimmune, Inc. Bruce began the professional journey as an Audit Senior Trainee Chartered Accountant at Crowe Clark Whitehill LLP. Bruce holds a BA (Hons.) in French and German from UCL and completed an Erasmus Year Abroad at Université Lyon III Jean Moulin in France and Universität Hamburg in Germany. Academic qualifications also include A Levels in French, German, English, and Maths from King Edward VI Five Ways School.